Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder

被引:51
|
作者
Toomey, R
Faraone, SV
Simpson, JC
Tsuang, MT
机构
[1] Harvard Univ, Sch Med, Dept Psychiat 116A, Brockton W Roxbury Vet Affairs Med Ctr, Brockton, MA 02301 USA
[2] Harvard Univ, Sch Med, Dept Psychiat 116A, Massachusetts Mental Hlth Ctr, Brockton, MA 02301 USA
[3] Harvard Univ, Inst Psychiat Epidemiol & Genet, Cambridge, MA 02138 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA
关键词
D O I
10.1097/00005053-199808000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We compared the factor structure of positive and negative symptoms in schizophrenia (N = 214), major depression (N = 97), and bipolar disorder (N = 58) to determine whether schizophrenia factors would generalize to mood disorders. A study of schizophrenia and mood disorders identified patients whose symptoms were evaluated with the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms. We conducted principal component analyses with orthogonal rotation on the global ratings. The factor structure replicated earlier findings of three factors (negative, positive, and disorganization) in groups with schizophrenia, combined mood disorders, and psychotic symptoms, regardless of diagnosis. An additional negative symptom factor was found in the major depression group. The bipolar group did not have a disorganization factor. Similar symptom factors in schizophrenia and mood disorders suggest a continuity in the major affective and psychotic disorders that appears to reflect the underlying dimension of a psychotic process.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 50 条
  • [41] REWARD SYSTEM DYSFUNCTION AND NEGATIVE SYMPTOM DIMENSIONS IN SCHIZOPHRENIA
    Kirschner, Matthias
    Hager, Oliver
    Hartmann, Matthias
    Kluge, Agne
    Bischof, Martin
    Seifritz, Erich
    Tobler, Philippe
    Kaiser, Stefan
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S331 - S332
  • [42] Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder
    C L Clelland
    V Drouet
    K C Rilett
    J A Smeed
    R H Nadrich
    A Rajparia
    L L Read
    J D Clelland
    Translational Psychiatry, 2016, 6 : e891 - e891
  • [43] Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder
    Clelland, C. L.
    Drouet, V.
    Rilett, K. C.
    Smeed, J. A.
    Nadrich, R. H.
    Rajparia, A.
    Read, L. L.
    Clelland, J. D.
    TRANSLATIONAL PSYCHIATRY, 2016, 6 : e891 - e891
  • [44] Candidate symptom and endophenotypes in autism, bipolar disorder and schizophrenia
    Leboyer, M
    Bellivier, F
    Schurhoff, F
    Plumet, MH
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 6S - 6S
  • [45] Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs
    Eastwood, SL
    Harrison, PJ
    MOLECULAR PSYCHIATRY, 2000, 5 (04) : 425 - 432
  • [46] A Comparative Study Of Neurological Soft Signs In Patients With Schizophrenia, Bipolar Disorder And Major Depression
    Rani, Rekha
    Jain, Sanjay
    Tripathi, Richa
    INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S234 - S234
  • [47] Candidate symptom and endophenotypes in autism, bipolar disorder and schizophrenia
    Leboyer, M
    Bellivier, F
    Henry, C
    Plumet, MH
    Rouillon, F
    EUROPEAN PSYCHIATRY, 2000, 15 : 54 - 55
  • [48] NRG-1 protein levels in patients with schizophrenia, bipolar disorder and major depression
    Beltaifa, S
    Webster, MJ
    Weickert, CS
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S116 - S116
  • [49] Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression
    Diaz, Francisco J.
    James, Danielle
    Botts, Sheila
    Maw, Lorraine
    Susce, Margaret T.
    de Leon, Jose
    BIPOLAR DISORDERS, 2009, 11 (02) : 154 - 165
  • [50] Serotonin transporter immunoreactivity in DRN subnuclei in schizophrenia, major depression, bipolar disorder and controls
    Boldrini, Maura
    Underwood, Mark D.
    Romoli, Anna Maria
    Mann, Joseph J.
    Arango, Victoria
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S259 - S259